ArticleJournal for immunotherapy of cancer2022

JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy.

Gabrielle Leclercq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.